Literature DB >> 29643793

Central Serous Chorioretinopathy Associated with Desmopressin Nasal Spray: Causality or Unfortunate Association.

Nacima Kisma1, Eleni Loukianou1, Bishwanath Pal1.   

Abstract

PURPOSE: To describe the possible association between central serous chorioretinopathy (CSCR) and desmopressin use.
METHODS: The case histories of 2 middle-aged men with CSCR using desmopressin nasal spray were studied.
RESULTS: The diagnosis of CSCR was made on the basis of clinical features and ancillary testing (fluorescein angiography and optical coherence tomography). Both patients were using desmopressin nasal spray for polyuria when they developed the first ocular symptoms. Both of them also had an independent risk factor for developing CSCR.
CONCLUSION: We suggest that desmopressin-induced hypercortisolism might implicate the development of CSCR in some patients. A larger study on patients using desmopressin nasal spray would be beneficial to confirm the possible association between this form of therapy and the development of CSCR.

Entities:  

Keywords:  Central serous chorioretinopathy; Desmopressin; Endogenous cortisol

Year:  2018        PMID: 29643793      PMCID: PMC5892319          DOI: 10.1159/000485912

Source DB:  PubMed          Journal:  Case Rep Ophthalmol        ISSN: 1663-2699


  14 in total

1.  Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex.

Authors:  A M Thoelen; P P Bernasconi; C Schmid; E P Messmer
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Central serous chorioretinopathy after local application of glucocorticoids for skin disorders.

Authors:  Panagiotis Karadimas; Anastasios Kapetanios; Evrydiki A Bouzas
Journal:  Arch Ophthalmol       Date:  2004-05

Review 3.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

4.  Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection.

Authors:  L Y Kao
Journal:  Retina       Date:  1998       Impact factor: 4.256

5.  Endocrine abnormalities in patients with central serous chorioretinopathy.

Authors:  Robert Haimovici; Shimon Rumelt; James Melby
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

6.  Endogenous cortisol profile in patients with central serous chorioretinopathy.

Authors:  S P Garg; T Dada; D Talwar; N R Biswas
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

7.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

8.  Central serous chorioretinopathy complicating systemic corticosteroid treatment.

Authors:  M Wakakura; S Ishikawa
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

9.  Effect of 1-deamino-5-D-arginine vasopressin (DDAVP) on plasma cortisol (hydrocortisone).

Authors:  J P Rado; E Juhos
Journal:  J Clin Pharmacol       Date:  1976-07       Impact factor: 3.126

10.  Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.

Authors:  J D Gass; H Little
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.